ALK Positive Inc. shared a post on LinkedIn:
“Until 2007, about one in twenty lung cancer patients all had one thing in common but did not know it: an alteration of the ALK gene that we’re all born with.
It’s thanks to research that we not only know about ALK-positive lung cancer but can effectively treat it for a longer life expectancy.
Dr Ross Camidge believes research can help us do even better. ”
